ICBio CRO is a full-service Contract Research Organization (CRO) headquartered in Bengaluru, India, that specializes in providing bioavailability/bioequivalence studies, clinical trials (phases I–IV), pharmacovigilance, and integrated clinical research solutions for studies ranging from PK studies in healthy volunteers to patient trials for generics and NCEs.

The ICBio team has excellent scientific expertise and the ability to handle difficult studies. With over 16 years of experience and over 90 delighted clients globally, the ICBio team completed 1000+ BA/BE studies and about 500 phase trials and submitted to and were approved by many regulatory bodies throughout the world, including ANVISA Brazil, DCGI-CDSCO, MHRA, EMA, TGA, MOH Iraq, UAE MOH, GCC, MOH Kazakhstan, and ZAMBIA regulatory, which have approved our organization. our Central Laboratory, which is fully integrated with LIMS and holds NABL accreditation/GCLP compliance. The NPRA Malaysia Accreditation is in progress.

Our cutting-edge clinical facility includes 100 beds and features full access control and UPS backup, ensuring the highest levels of research integrity and patient care. Our clinical facility has 3 independent air-conditioned CPUs with ICU facilities with access control and UPS backup for facilitating the simultaneous condition of multiple studies, resulting in quick turnaround time. Our bio-analytical facility has SCIEX 4000, SCIEX 4500 Series, SCIEX 5500, Shimadzu 8040 & 8050 mass spectrometers, and PerkinElmer ICP-MS. Developed and validated methods for 200 molecules. State-of-the-Art Facilities & Large Database of Study Volunteers.